Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...
Surgery for refractory constipation should be a last resort, used only after comprehensive physiologic and psychological ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
As part of the new schedule, HHS will no longer broadly recommend influenza, COVID-19, rotavirus, and other previously ...
Conditional market access schemes can accelerate access to effective new treatments. To better balance their costs and health benefits, collaborative negotiation is key in pricing.
This empirical study demonstrates that a multi-criteria decision analysis (MCDA) framework is a feasible and consistent supplementary tool for evaluating the value of orphan medicinal products (OMPs) ...
Morning Overview on MSN
US rewrites the childhood vaccine schedule in a major shake-up
The United States has just carried out the most sweeping rewrite of its childhood vaccine guidance in decades, cutting back ...
Learn about Agentic AI and its role in enhancing decision-making in drug discovery through planned actions and verified ...
AZoMaterials speaks to Dr. Simon Bates and Dr. Angela Criswell about how X-ray CT imaging is transforming tablet design and quality control, revealing how microstructure drives dissolution, ...
The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback